Novel genetic and epigenetic alterations in ... - Ous-research.no

More documents

Recommendations

Info

References84. Kunkel TA (1993) Nucleotide repeats. Slippery DNA and diseases. Nature365(6443): 207-20885. Loeb LA, Monnat RJ, Jr. (2008) DNA polymerases and human disease. Nat RevGenet 9(8): 594-60486. Kunkel TA, Bebenek K (2000) DNA replication fidelity. Annu Rev Biochem69:497-529. 497-52987. Kuismanen SA, Holmberg MT, Salovaara R, de la CA, Peltomäki P (2000) Geneticand epigenetic modification of MLH1 accounts for a major share ofmicrosatellite-unstable colorectal cancers. Am J Pathol 156(5): 1773-177988. Duval A, Iacopetta B, Thorstensen L, Meling GI, Lothe RA, Thuille B, Suraweera N,Thomas G, Hamelin R (2001) Gender difference for mismatch repair deficiencyin human colorectal cancer. Gastroenterology 121(4): 1026-102789. Kroutil LC, Register K, Bebenek K, Kunkel TA (1996) Exonucleolyticproofreading during replication of repetitive DNA. Biochemistry 35(3): 1046-105390. Røyrvik EC, Ahlquist T, Rognes T, Lothe RA (2007) Slip slidin' away: aduodecennial review of targeted genes in mismatch repair deficient colorectalcancer. Crit Rev Oncog 13(3): 229-25791. Shibata D, Peinado MA, Ionov Y, Malkhosyan S, Perucho M (1994) Genomicinstability in repeated sequences is an early somatic event in colorectaltumorigenesis that persists after transformation. Nat Genet 6(3): 273-28192. Issa JP (2004) CpG island methylator phenotype in cancer. Nat Rev Cancer4(12): 988-99393. Goel A, Arnold CN, Niedzwiecki D, Chang DK, Ricciardiello L, Carethers JM,Dowell JM, Wasserman L, Compton C, Mayer RJ, Bertagnolli MM, Boland CR(2003) Characterization of sporadic colon cancer by patterns of genomicinstability. Cancer Res 63(7): 1608-161494. Shen L, Catalano PJ, Benson AB, III, O'Dwyer P, Hamilton SR, Issa JP (2007)Association between DNA methylation and shortened survival in patientswith advanced colorectal cancer treated with 5-fluorouracil basedchemotherapy. Clin Cancer Res 13(20): 6093-609895. Teodoridis JM, Hardie C, Brown R (2008) CpG island methylator phenotype(CIMP) in cancer: causes and implications. Cancer Lett 268(2): 177-18696. van RM, Elsaleh H, Joseph D, McCaul K, Iacopetta B (2003) CpG islandmethylator phenotype is an independent predictor of survival benefit from 5-fluorouracil in stage III colorectal cancer. Clin Cancer Res 9(8): 2898-290374
References97. Samowitz WS, Albertsen H, Herrick J, Levin TR, Sweeney C, Murtaugh MA, WolffRK, Slattery ML (2005) Evaluation of a large, population-based samplesupports a CpG island methylator phenotype in colon cancer. Gastroenterology129(3): 837-84598. Shen L, Toyota M, Kondo Y, Lin E, Zhang L, Guo Y, Hernandez NS, Chen X,Ahmed S, Konishi K, Hamilton SR, Issa JP (2007) Integrated genetic andepigenetic analysis identifies three different subclasses of colon cancer. ProcNatl Acad Sci U S A 104(47): 18654-1865999. Samowitz WS, Slattery ML, Sweeney C, Herrick J, Wolff RK, Albertsen H (2007)APC mutations and other genetic and epigenetic changes in colon cancer.Mol Cancer Res 5(2): 165-170100. Yang S, Farraye FA, Mack C, Posnik O, O'Brien MJ (2004) BRAF and KRASMutations in hyperplastic polyps and serrated adenomas of the colorectum:relationship to histology and CpG island methylation status. Am J Surg Pathol28(11): 1452-1459101. van RM, Grieu F, Elsaleh H, Joseph D, Iacopetta B (2002) Characterisation ofcolorectal cancers showing hypermethylation at multiple CpG islands. Gut51(6): 797-802102. Whitehall VL, Wynter CV, Walsh MD, Simms LA, Purdie D, Pandeya N, Young J,Meltzer SJ, Leggett BA, Jass JR (2002) Morphological and molecularheterogeneity within nonmicrosatellite instability-high colorectal cancer.Cancer Res 62(21): 6011-6014103. Anacleto C, Leopoldino AM, Rossi B, Soares FA, Lopes A, Rocha JC, Caballero O,Camargo AA, Simpson AJ, Pena SD (2005) Colorectal cancer "methylatorphenotype": fact or artifact? Neoplasia 7(4): 331-335104. Lee S, Hwang KS, Lee HJ, Kim JS, Kang GH (2004) Aberrant CpG islandhypermethylation of multiple genes in colorectal neoplasia. Lab Invest 84(7):884-893105. Yamashita K, Dai T, Dai Y, Yamamoto F, Perucho M (2003) Genetics supersedesepigenetics in colon cancer phenotype. Cancer Cell 4(2): 121-131106. Issa JP, Shen L, Toyota M (2005) CIMP, at last. Gastroenterology 129(3): 1121-1124107. Goel A, Nagasaka T, Arnold CN, Inoue T, Hamilton C, Niedzwiecki D, Compton C,Mayer RJ, Goldberg R, Bertagnolli MM, Boland CR (2007) The CpG islandmethylator phenotype and chromosomal instability are inversely correlated insporadic colorectal cancer. Gastroenterology 132(1): 127-138108. Weisenberger DJ, Siegmund KD, Campan M, Young J, Long TI, Faasse MA, KangGH, Widschwendter M, Weener D, Buchanan D, Koh H, Simms L, Barker M,75
Page 1 and 2:
Novel genetic and epigenetic altera
Page 3 and 4:
TABLE OF CONTENTSACKNOWLEDGEMENTS .
Page 5 and 6:
ACKNOWLEDGEMENTSThe present work ha
Page 7 and 8:
Prefacetechnology[3]. This new tech
Page 10 and 11:
SummaryThe subgroup of carcinomas w
Page 12 and 13:
Introduction“Epigenetic inheritan
Page 14 and 15:
Introductionamino acid change it is
Page 16 and 17:
Introductionmethylation during embr
Page 18 and 19:
IntroductionDNA is most of the time
Page 20 and 21:
IntroductionFigure 5. DNA methylati
Page 22 and 23:
IntroductionFigure 6. Incidence rat
Page 24 and 25: IntroductionFigure 8. Tumor staging
Page 26 and 27: Introductioninasmuch as 80% of colo
Page 28 and 29: IntroductionInstabilities involved
Page 30 and 31: Introductionthere seems to be a fid
Page 32 and 33: Introductionsevere alterations are
Page 34 and 35: Introductionpopulation-wide screeni
Page 36 and 37: IntroductionFigure 12. Present and
Page 38 and 39: RESULTS IN BRIEFPaper Ia. “DNA hy
Page 40 and 41: Results in Briefinstability, and se
Page 42 and 43: Results in BriefUnivariate survival
Page 44 and 45: Discussionseveral factors, and full
Page 46 and 47: Discussionlow threshold, we increas
Page 48 and 49: DiscussionIt may seem like unnecess
Page 50 and 51: Discussionthan 96% DHPLC do not sta
Page 52 and 53: DiscussionFigure 13. Mutation detec
Page 54 and 55: DiscussionClinical impact of molecu
Page 56 and 57: Discussionmarkers with a very high
Page 58 and 59: Discussionchromosomes in metaphase[
Page 60 and 61: DiscussionThese examples underline
Page 62 and 63: Discussiongenes. One is based on mu
Page 64 and 65: CONCLUSIONSWe have identified novel
Page 66 and 67: Future PerspectivesMolecular risk a
Page 68 and 69: REFERENCES1. Breasted J (1930) The
Page 70 and 71: References29. Deng G, Chen A, Pong
Page 72 and 73: References57. Al-Sukhni W, Aronson
Page 76 and 77: ReferencesLeggett B, Levine J, Kim
Page 78 and 79: References133. Lind GE, Thorstensen
Page 80 and 81: References156. Meling GI, Lothe RA,
Page 82 and 83: ReferencesT, Song X, Day RH, Sledzi
Page 84 and 85: References196. Honda S, Haruta M, S
Page 86 and 87: ORIGINAL ARTICLESAPPENDIXAppendix I
Page 89 and 90: GASTROENTEROLOGY 2007;132:1631-1639
Page 91: Paper IbGuro E Lind, Terje Ahlquist
Page 94 and 95: Journal of Translational Medicine 2
Page 105: Paper IITerje Ahlquist, Guro E Lind
Page 108 and 109: BackgroundMost cases of colorectal
Page 110 and 111: ADAMTS1 CDKN2A CRABP1 HOXA9 MAL MGM
Page 112 and 113: pseudogene, leading to a high rate
Page 114 and 115: strands. Proc Natl Acad Sci U S A 1
Page 116 and 117: concomitant absence of transcript a
Page 119 and 120: Volume 10 Number 7 July 2008 pp. 68
Page 121 and 122: 682 RAS Signaling in Colorectal Car
Page 123 and 124: 684 RAS Signaling in Colorectal Car
Page 125 and 126:
686 RAS Signaling in Colorectal Car
Page 127:
Table W2. Detailed Somatic Events o
Page 131 and 132:
Identification of RCC2 as a prognos
Page 133 and 134:
INTRODUCTIONMicrosatellite instabil
Page 135 and 136:
unselected series of primary tumors
Page 137 and 138:
specificity, i.e. that they only am
Page 139 and 140:
On the assumption that DNA repair a
Page 141 and 142:
In order to ensure that gene mutati
Page 143 and 144:
Figure 2. Mutation frequency differ
Page 145 and 146:
and TAF1B (0.50), ACVR2A and ASTE1
Page 147 and 148:
Multivariate analysesA multivariate
Page 149 and 150:
When comparing our findings of muta
Page 151 and 152:
The test series included a low numb
Page 153 and 154:
entering M-phase remains to be seen
Page 155 and 156:
12. Duval A, Reperant M, Hamelin R
Page 157 and 158:
34. Martineau-Thuillier S, Andreass
Page 159:
AppendicesAppendix I:List of abbrev
Page 163 and 164:
Critical Reviews TM in Oncogenesis,
Page 165 and 166:
TARGET GENES OF MSI COLORECTAL CANC
Page 167 and 168:
Page 169 and 170:
Page 171 and 172:
Page 173 and 174:
Page 175 and 176:
Page 177 and 178:
Page 179 and 180:
Page 181 and 182:
Page 183 and 184:
Page 185 and 186:
Page 187 and 188:
Page 189 and 190:
Page 191:
show all

Novel genetic and epigenetic alterations in ... - Ous-research.no

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?